Impax deploys Revitas strategic Flex technology platform
As per the new agreement, Impax will implement the Flex platform, which will drive the expansion of Revitas solutions across the enterprise from the generics division to the
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.